The immune response in autism: a new frontier for autism research
The DOI matches its Crossref record; 202 of the 202 references it cites were found in a registry or an index.
Abstract
Autism spectrum disorders (ASD) are part of a broad spectrum of neurodevelopmental disorders known as pervasive developmental disorders, which occur in childhood. They are characterized by impairments in social interaction, verbal and nonverbal communication and the presence of restricted and repetitive stereotyped behaviors. At the present time, the etiology of ASD is largely unknown, but genetic, environmental, immunological, and neurological factors are thought to play a role in the development of ASD. Recently, increasing research has focused on the connections between the immune system and the nervous system, including its possible role in the development of ASD. These neuroimmune interactions begin early during embryogenesis and persist throughout an individual’s lifetime, with successful neurodevelopment contingent upon a normal balanced immune response. Immune aberrations consistent with a dysregulated immune response, which so far, have been reported in autistic children, include abnormal or skewed T helper cell type 1 (TH1)/TH2 cytokine profiles, decreased lymphocyte numbers, decreased T cell mitogen response, and the imbalance of serum immunoglobulin levels. In addition, autism has been linked with autoimmunity and an association with immune-based genes including human leukocyte antigen (HLA)-DRB1 and complement C4 alleles described. There is potential that such aberrant immune activity during vulnerable and critical periods of neurodevelopment could participate in the generation of neurological dysfunction characteristic of ASD. This review will examine the status of the research linking the immune response with ASD.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“There is substantial evidence that the immune response alters the development of the CNS during fetal life8, 9”
From Elevated maternal C-reactive protein and autism in a national birth cohort (2014) · cites this paper as [9]
In the citing paper
“Numerous immune irregularities have been reported in children with ASD (Ashwood et al., 2011a; Ashwood et al., 2011b; Ashwood et al., 2006), especially with inflammatory cytokines.”
From Maternal hospitalization with infection during pregnancy and risk of autism spectrum disorders (2015) · cites this paper as Ashwood et al., 2006
In the citing paper
“Specifically, there is an association between ASD and maternal infection requiring hospitalization during pregnancy, elevated C-reactive protein, and a family history of autoimmune diseases.”
From Gut microbiota changes in children with autism spectrum disorder: a systematic review (2020) · cites this paper as [78]
In the citing paper
“Prior literature has substantiated that infections during pregnancy have been correlated with increased frequency of neurodevelopmental disorders in offspring [16, 17, 76–78].”
From Gut microbiota changes in children with autism spectrum disorder: a systematic review (2020) · cites this paper as [78]
Citations
Cites
2 retracted
Wakefield, A., Murch, S., Anthony, A., Linnell, J., Casson, D., Malik, M., Berelowitz, M., Dhillon, A., Thomson, M., Harvey, P., et al. (1998) · The Lancet · doi:10.1016/s0140-6736(97)11096-0 · Cited by 3,006
RetractedEnterocolitis in children with developmental disorders
Wakefield, A. J., Anthony, A., MURCH, S. H., Thomson, M. A., Montgomery, S., Davies, S. E., O’Leary, J. J., Berelowitz, M., & Walker-Smith, J. A. (2000) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(00)02041-4 · Cited by 246 · cited 1×
“mation and eosinophil infiltration [118–120].”
RetractedDiagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. (2013) · Encyclopedia of Social Work · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,519
Rice, D., & Barone, S. (2000) · Environmental Health Perspectives · doi:10.1289/ehp.00108s3511 · Cited by 2,944 · cited 1×
“There are multiple, critical timepoints in neurodevelopment, including proliferation, migration, differentiation, synaptogenesis, gliogenesis, myelination, and apoptosis of neurons [14].”
BackgroundMendelson, G. (1995) · Australian & New Zealand Journal of Psychiatry · doi:10.3109/00048679509064964 · Cited by 2,858
Autism as a strongly genetic disorder: evidence from a British twin study
Bailey, A., Le Couteur, A., Gottesman, I., Bolton, P., Simonoff, E., Yuzda, E., & Rutter, M. (1995) · Psychological Medicine · doi:10.1017/s0033291700028099 · Cited by 2,461 · cited 1×
“children with ASD is estimated between 2% and 6% [8].”
BackgroundNeuroglial activation and neuroinflammation in the brain of patients with autism
Vargas, D. L., Nascimbene, C., Krishnan, C., Zimmerman, A. W., & Pardo, C. A. (2005) · Annals of Neurology · doi:10.1002/ana.20315 · Cited by 2,149 · cited 1×
“[67] investigated the presence of immune activation in postmortem brain specimens and CSF from subjects with autism.”
BackgroundUnusual brain growth patterns in early life in patients with autistic disorder: An MRI study
Courchesne, E., Karns, C. M., Davis, H. R., Ziccardi, R., Carper, R. A., Tigue, Z. D., Chisum, H. J., Moses, P., Pierce, K., Lord, C., et al. (2001) · Neurology · doi:10.1212/wnl.57.2.245 · Cited by 1,487
Social amnesia in mice lacking the oxytocin gene
Ferguson, J. N., Young, L. J., Hearn, E. F., Matzuk, M. M., Insel, T. R., & Winslow, J. T. (2000) · Nature Genetics · doi:10.1038/77040 · Cited by 1,130 · cited 1×
“Furthermore, oxytocin knockout mice have normal, cognitive abilities but diminished social recognition, suggesting a key role of oxytocin in social interactions [96].”
BackgroundHofman, A., Ott, A., Breteler, M. M., Bots, M. L., Slooter, A. J., van Harskamp, F., van Duijn, C. N., Van Broeckhoven, C., & Grobbee, D. E. (1997) · The Lancet · doi:10.1016/s0140-6736(96)09328-2 · Cited by 1,062 · cited 1×
“Vascular changes related with aging (artherosclerosis, hypertension) are risk factors for AD [194, 195].”
Background
Research works printed but not linked: 7
- Cook, 1998, Genetics of autism, Ment. Retard. Dev. Disabil. Res. Rev., 4, 113, 10.1002/(SICI)1098-2779(1998)4:2<113::AID-MRDD8>3.0.CO;2-Q · DOI · Paper page
- Villalobos, 1996, Prolonged EEG monitoring findings in children with pervasive developmental disorder and regression, Ann. Neurol., 40, 300
- Licinio, 1998, Cytokines and brain function: relevance to interferon-α-induced mood and cognitive changes, Semin. Oncol., 25, 30
- Chugani, 1999, Developmental changes in brain serotonin synthesis capacity in autistic and nonautistic children, Ann. Neurol., 45, 287, 10.1002/1531-8249(199903)45:3<287::AID-ANA3>3.0.CO;2-9 · doi:10.1002/1531-8249(199903)45:3<287::aid-ana3>3.0.co;2-9
- Rumsey, 2000, Functional neuroimaging of autistic disorders, Ment. Retard. Dev. Disabil. Res. Rev., 6, 171, 10.1002/1098-2779(2000)6:3<171::AID-MRDD4>3.0.CO;2-N · doi:10.1002/1098-2779(2000)6:3<171::aid-mrdd4>3.0.co;2-n
- Ashwood, 2003, Intestinal lymphoctye populations in children with regressive autism: evidence for extensive mucosal immunopathology, J. Clin. Immunol., 23, 504, 10.1023/B:JOCI.0000010427.05143.bb · DOI · Paper page
- Knivsberg, 2002, A randomized, controlled study of dietary intervention in autistic syndromes, Nutr. Neurosci., 5, 251, 10.1080/10284150290028945 · DOI · Paper page
Cited by
The maternal interleukin-17a pathway in mice promotes autism-like phenotypes in offspring
Choi, G. B., Yim, Y. S., Wong, H., Kim, S., Kim, H., Kim, S. V., Hoeffer, C. A., Littman, D. R., & Huh, J. R. (2016) · Science · doi:10.1126/science.aad0314 · Cited by 1,214
Control of brain development, function, and behavior by the microbiome
Sampson, T. R., & Mazmanian, S. K. (2015) · Cell Host & Microbe · doi:10.1016/j.chom.2015.04.011 · Cited by 1,093
“In the maternal immune activation (MIA) model of autism, a decrease in regulatory T cells and an increase in pro-inflammatory innate monocytes are observed in mice that display ASD symptoms.”
InfluentialAn Overview of Autism Spectrum Disorder, Heterogeneity and Treatment Options
Masi, A., DeMayo, M. M., Glozier, N., & Guastella, A. J. (2017) · Neuroscience Bulletin · doi:10.1007/s12264-017-0100-y · Cited by 987
Oxytocin and the Neural Mechanisms Regulating Social Cognition and Affiliative Behavior
Ross, H. E., & Young, L. J. (2009) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2009.05.004 · Cited by 856
“Functioning of the immune system has become of interest in the context of autism spectrum disorders since these disorders have been associated with a vulnerability to toxins and excessive food allergies [85-88].”
BackgroundBuie, T., Campbell, D. B., Fuchs, G. J., Furuta, G. T., Levy, J., VandeWater, J., Whitaker, A. H., Atkins, D., Bauman, M. L., Beaudet, A. L., et al. (2010) · Pediatrics · doi:10.1542/peds.2009-1878c · Cited by 872
Morgan, J. T., Chana, G., Pardo, C. A., Achim, C., Semendeferi, K., Buckwalter, J., Courchesne, E., & Everall, I. P. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.05.024 · Cited by 749
“euroimmune abnormalities have been linked to the pathogenesis of autism (1,2).”
BackgroundMicroglial Activation in Young Adults With Autism Spectrum Disorder
Suzuki, K., Sugihara, G., Ouchi, Y., Nakamura, K., Futatsubashi, M., Takebayashi, K., Yoshihara, Y., Omata, K., Matsumoto, K., Tsuchiya, K. J., et al. (2013) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2013.272 · Cited by 523
Pardo, C. A., & Eberhart, C. G. (2007) · Brain Pathology · doi:10.1111/j.1750-3639.2007.00102.x · Cited by 514
Williams, B. L., Hornig, M., Buie, T., Bauman, M. L., Cho Paik, M., Wick, I., Bennett, A., Jabado, O., Hirschberg, D. L., & Lipkin, W. I. (2011) · PLoS ONE · doi:10.1371/journal.pone.0024585 · Cited by 492
“Associated changes in intestinal inflammatory parameters include higher densities of lymphocyte populations, aberrant cytokine profiles, and deposition of immunoglobulin (IgG) and complement C1q on the basolateral enterocyte membrane [5,8,9,10,11,12].”
BackgroundCytokine aberrations in autism spectrum disorder: a systematic review and meta-analysis
Masi, A., Quintana, D. S., Glozier, N., Lloyd, A. R., Hickie, I. B., & Guastella, A. J. (2015) · Molecular Psychiatry · doi:10.1038/mp.2014.59 · Cited by 466
Hematopoietic origin of pathological grooming in Hoxb8 mutant mice
Chen, S.-K., Tvrdik, P., Peden, E., Cho, S., Wu, S., Spangrude, G., & Capecchi, M. R. (2010) · Cell · doi:10.1016/j.cell.2010.03.055 · Cited by 450
“…have been widely linked to many psychiatric disorders including OCD, major depression, bipolar disorder, autism, schizophrenia, and Alzheimer’s disease (Ashwood et al., 2006; da Rocha et al., 2008; Kronfol and Remick, 2000; Lang et al., 2007; Leonard and Myint, 2009; Strous and Shoenfeld, 2006).”
BackgroundMazurek, M. O., Vasa, R. A., Kalb, L. G., Kanne, S. M., Rosenberg, D., Keefer, A., Murray, D. S., Freedman, B., & Lowery, L. A. (2013) · Journal of Abnormal Child Psychology · doi:10.1007/s10802-012-9668-x · Cited by 419
“Alterations in these same immune markers have also been reported among individuals with ASD (Ashwood et al. 2006), suggesting another potential common mechanism for GI problems and anxiety in this population.”
BackgroundAssociation of Family History of Autoimmune Diseases and Autism Spectrum Disorders
Atladóttir, H. O., Pedersen, M. G., Thorsen, P., Mortensen, P. B., Deleuran, B., Eaton, W. W., & Parner, E. T. (2009) · Pediatrics · doi:10.1542/peds.2008-2445 · Cited by 404
“Primary analyses involve investigating significant findings from previous studies, that is, the relationship between ASDs or infantile autism and (1) family history of all ADs combined, (2) family history of RA, (3) maternal psoriasis, (4) paternal T1D, (5) maternal ulcerative colitis, and (6) family history of AD in…”
BackgroundImmune transcriptome alterations in the temporal cortex of subjects with autism
Garbett, K., Ebert, P. J., Mitchell, A., Lintas, C., Manzi, B., Mirnics, K., & Persico, A. M. (2008) · Neurobiology of Disease · doi:10.1016/j.nbd.2008.01.012 · Cited by 375
“…autism is not novel; epidemiological, (DeLong et al., 1981; Yamashita et al., 2003; Libbey et al., 2005) serological studies (Vargas et al., 2005; Ashwood et al., 2006) and postmortem studies (Pardo et al., 2005; Vargas et al., 2005; Korkmaz et al., 2006) over the last 10 years have provided…”
InfluentialWilliams, B. L., Hornig, M., Parekh, T., & Lipkin, W. I. (2012) · mBio · doi:10.1128/mbio.00261-11 · Cited by 378
Elevated maternal C-reactive protein and autism in a national birth cohort
Brown, A. S., Sourander, A., Hinkka-Yli-Salomäki, S., McKeague, I. W., Sundvall, J., & Surcel, H.-M. (2014) · Molecular Psychiatry · doi:10.1038/mp.2012.197 · Cited by 343
Goines, P. E., Croen, L. A., Braunschweig, D., Yoshida, C. K., Grether, J., Hansen, R., Kharrazi, M., Ashwood, P., & Van de Water, J. (2011) · Molecular Autism · doi:10.1186/2040-2392-2-13 · Cited by 351
“Evidence has linked various types of maternal immune activation and dysregulation to behavioral disorders, including ASD [7,8].”
BackgroundSelf-citationMaternal hospitalization with infection during pregnancy and risk of autism spectrum disorders
Lee, B. K., Magnusson, C., Gardner, R. M., Blomström, Å., Newschaffer, C. J., Burstyn, I., Karlsson, H., & Dalman, C. (2015) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2014.09.001 · Cited by 337
Bilbo, S. D., Block, C. L., Bolton, J. L., Hanamsagar, R., & Tran, P. K. (2018) · Experimental Neurology · doi:10.1016/j.expneurol.2017.07.002 · Cited by 319
“…to antigen, altered cytokine production, and an increased incidence of allergies and other autoimmune disorders (Ashwood and Wakefield, 2006; Ashwood et al., 2006; Blaylock, 2009; Blaylock and Strunecka, 2009; Derecki et al., 2010; Enstrom et al., 2010; Maezawa and Jin, 2010; Pardo et al.,…”
Reversing behavioural abnormalities in mice exposed to maternal inflammation
Shin Yim, Y., Park, A., Berrios, J., Lafourcade, M., Pascual, L. M., Soares, N., Yeon Kim, J., Kim, S., Kim, H., Waisman, A., et al. (2017) · Nature · doi:10.1038/nature23909 · Cited by 303
Microglia in the Cerebral Cortex in Autism
Tetreault, N. A., Hakeem, A. Y., Jiang, S., Williams, B. A., Allman, E., Wold, B. J., & Allman, J. M. (2012) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-012-1513-0 · Cited by 288
Autism: Definition, Neurobiology, Screening, Diagnosis
Rapin, I., & Tuchman, R. F. (2008) · Pediatric Clinics of North America · doi:10.1016/j.pcl.2008.07.005 · Cited by 281
Altered T cell responses in children with autism
Ashwood, P., Krakowiak, P., Hertz-Picciotto, I., Hansen, R., Pessah, I. N., & Van de Water, J. (2011) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2010.09.002 · Cited by 281
Self-citationInfection with a Helminth Parasite Prevents Experimental Colitis via a Macrophage-Mediated Mechanism
Smith, P., Mangan, N. E., Walsh, C. M., Fallon, R. E., McKenzie, A. N. J., van Rooijen, N., & Fallon, P. G. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.7.4557 · Cited by 279
Cannell, J. J. (2008) · Medical Hypotheses · doi:10.1016/j.mehy.2007.08.016 · Cited by 279
Ashwood, P., Enstrom, A., Krakowiak, P., Hertz-Picciotto, I., Hansen, R. L., Croen, L. A., Ozonoff, S., Pessah, I. N., & de Water, J. V. (2008) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2008.07.006 · Cited by 271
“…several studies have shown peripheral immune abnormalities in patients with autism including abnormal or skewed T helper cell cytokine profiles, decreased lymphocyte numbers, decreased T cell mitogen response, and an imbalance of serum immunoglobulin levels [reviewed in Ashwood et al., 2006a].”
Self-citationBrain IL-6 elevation causes neuronal circuitry imbalances and mediates autism-like behaviors
Wei, H., Chadman, K. K., McCloskey, D. P., Sheikh, A. M., Malik, M., Brown, W. T., & Li, X. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2012.01.011 · Cited by 259
Enstrom, A. M., Lit, L., Onore, C. E., Gregg, J. P., Hansen, R. L., Pessah, I. N., Hertz-Picciotto, I., Van de Water, J. A., Sharp, F. R., & Ashwood, P. (2009) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2008.08.001 · Cited by 257
“Despite expanding research in ASD, its etiologies remain poorly understood and the relative contribution from genetic, epigenetic, and environmental susceptibility factors remains widely debated (Ashwood et al., 2006).”
BackgroundSelf-citationPlasma Cytokine Profiles in Subjects with High-Functioning Autism Spectrum Disorders
Suzuki, K., Matsuzaki, H., Iwata, K., Kameno, Y., Shimmura, C., Kawai, S., Yoshihara, Y., Wakuda, T., Takebayashi, K., Takagai, S., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0020470 · Cited by 252
“Accumulating evidence suggests that dysregulation of the immune system may be implicated in the pathophysiology of ASD [3,4].”
BackgroundResultThe immune system's role in the biology of autism
Goines, P., & Van de Water, J. (2010) · Current Opinion in Neurology · doi:10.1097/wco.0b013e3283373514 · Cited by 245
“While there are no concrete biological markers for the disorder, immune anomalies are frequently described among individuals with ASD and their family members [2,3].”
BackgroundImmune Dysfunction and Autoimmunity as Pathological Mechanisms in Autism Spectrum Disorders
Hughes, H. K., Mills Ko, E., Rose, D., & Ashwood, P. (2018) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2018.00405 · Cited by 245
Self-citationEnvironmental Factors in Autism
Grabrucker, A. M. (2013) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2012.00118 · Cited by 235
“Parental age is correlated with an increased risk of maternal autoimmunity as the majority of autoimmune disorders are manifest between 30 years of age and upward (Ashwood et al., 2006).”
BackgroundInfluentialTaliou, A., Zintzaras, E., Lykouras, L., & Francis, K. (2013) · Clinical Therapeutics · doi:10.1016/j.clinthera.2013.04.006 · Cited by 233
“benefit could be through reduction of brain inflammation and may be due to inhibition of different inflammatory processes (many of which involve mast cells), because a subgroup of subjects with ASD present with some immune dysfunction.(16) Both raw and age-equivalent scores (except for the communication raw score) wer…”
BackgroundThe Microbiome in Psychology and Cognitive Neuroscience
Sarkar, A., Harty, S., Lehto, S. M., Moeller, A. H., Dinan, T. G., Dunbar, R. I. M., Cryan, J. F., & Burnet, P. W. J. (2018) · Trends in Cognitive Sciences · doi:10.1016/j.tics.2018.04.006 · Cited by 232
“Autism has also been linked to gastroenterological and immunological dysregulation, as well as variation in microbial content[102-107].”
BackgroundGaray, P. (2010) · Frontiers in Synaptic Neuroscience · doi:10.3389/fnsyn.2010.00136 · Cited by 217
“The immune system appears to influence the nervous system during typical to controls (Pardo et al., 2005; Ashwood et al., 2006; Garbett et al., 2008; Meyer et al., 2008a; Enstrom et al., 2009).”
BackgroundImmunological and autoimmune considerations of Autism Spectrum Disorders
Gesundheit, B., Rosenzweig, J. P., Naor, D., Lerer, B., Zachor, D. A., Procházka, V., Melamed, M., Kristt, D. A., Steinberg, A., Shulman, C., et al. (2013) · Journal of Autoimmunity · doi:10.1016/j.jaut.2013.05.005 · Cited by 207
“Large studies of antibodies in ASD suggest clinical correlation with disease’s severity [60].”
Self-citationAutism spectrum disorder causes, mechanisms, and treatments: focus on neuronal synapses
Won, H., Mah, W., & Kim, E. (2013) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2013.00019 · Cited by 206
Genetics of autoimmune diseases — disorders of immune homeostasis
Gregersen, P. K., & Behrens, T. W. (2006) · Nature Reviews Genetics · doi:10.1038/nrg1944 · Cited by 204
Goldani, A. A. S., Downs, S. R., Widjaja, F., Lawton, B., & Hendren, R. L. (2014) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2014.00100 · Cited by 180
“An imbalance in Th1/Th2 has are found as well, which may play a role in the pathogenesis of autism (115).”
BackgroundKalkbrenner, A. E., Windham, G. C., Serre, M. L., Akita, Y., Wang, X., Hoffman, K., Thayer, B. P., & Daniels, J. L. (2015) · Epidemiology · doi:10.1097/ede.0000000000000173 · Cited by 197
Reduced levels of immunoglobulin in children with autism correlates with behavioral symptoms
Heuer, L., Ashwood, P., Schauer, J., Goines, P., Krakowiak, P., Hertz‐Picciotto, I., Hansen, R., Croen, L. A., Pessah, I. N., & Van de Water, J. (2008) · Autism Research · doi:10.1002/aur.42 · Cited by 190
Self-citationImmune dysfunction and neuroinflammation in autism spectrum disorder
Bjørklund, G., Saad, K., Chirumbolo, S., K. Kern, J., A. Geier, D., R. Geier, M., & A. Urbina, M. (2016) · Acta Neurobiologiae Experimentalis · doi:10.21307/ane-2017-025 · Cited by 189
“The presence of autoantibodies towards central nervous system (CNS) proteins is a common finding in ASD and may reflect an ongoing inflammatory and or autoimmune process in individuals with ASD that could be started by abnormal NK cell activation (Ashwood et al. 2006).”
Biomarkers in autism spectrum disorder: the old and the new
Ruggeri, B., Sarkans, U., Schumann, G., & Persico, A. M. (2014) · Psychopharmacology · doi:10.1007/s00213-013-3290-7 · Cited by 188
“Many autistic individuals display immune abnormalities (Ashwood et al. 2006), including elevated IL-1, IFN-γ and TNF-α levels in the plasma and/or cerebrospinal fluid, increased production of the anti-inflammatory cytokine IL-10 and abnormal post-thymic maturation of T lymphocytes with increased…”
BackgroundUnderstanding and Determining the Etiology of Autism
Currenti, S. A. (2010) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-009-9453-8 · Cited by 182
Gene expression changes in children with autism
Gregg, J. P., Lit, L., Baron, C. A., Hertz-Picciotto, I., Walker, W., Davis, R. A., Croen, L. A., Ozonoff, S., Hansen, R., Pessah, I. N., et al. (2008) · Genomics · doi:10.1016/j.ygeno.2007.09.003 · Cited by 181
Mitochondrial dysfunction in autism spectrum disorders: Cause or effect?
Palmieri, L., & Persico, A. M. (2010) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2010.04.018 · Cited by 173
“Finally, large subgroups of ASD patients also display systemic signs and symptoms, including macrosomy [11], non-speci fi c enterocolitis [12], immune dysreactivity [12,13] and renal oligopeptiduria[14].”
BackgroundLv, Y.-T., Zhang, Y., Liu, M., Qiuwaxi, J.-N.-T., Ashwood, P., Cho, S. C., Huan, Y., Ge, R.-C., Chen, X.-W., Wang, Z.-J., et al. (2013) · Journal of Translational Medicine · doi:10.1186/1479-5876-11-196 · Cited by 174
“Various autoantibodies responding to the proteins in central nervous system have been detected in the children with autism, which might link autism with an autoimmune process rather than an externally triggered immune reaction [27-29].”
BackgroundSelf-citationMaternal Mid-Pregnancy Autoantibodies to Fetal Brain Protein: The Early Markers for Autism Study
Croen, L. A., Braunschweig, D., Haapanen, L., Yoshida, C. K., Fireman, B., Grether, J. K., Kharrazi, M., Hansen, R. L., Ashwood, P., & Van de Water, J. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.05.006 · Cited by 171
“Immune system dysregulation has been reported in ASD in several studies (reviewed by Ashwood et al. 2006) (5).”
BackgroundSelf-citationAberrant immune responses in a mouse with behavioral disorders
Heo, Y., Zhang, Y., Gao, D., Miller, V. M., & Lawrence, D. A. (2011) · PLoS ONE · doi:10.1371/journal.pone.0020912 · Cited by 168
“In autistic subjects, immune alterations, particularly cytokine modulations, that affect the pathogenesis of autism development, are not agreed upon [23,62].”
BackgroundResultInfluentialParental Autoimmune Diseases Associated With Autism Spectrum Disorders in Offspring
Keil, A., Daniels, J. L., Forssen, U., Hultman, C., Cnattingius, S., Söderberg, K. C., Feychting, M., & Sparen, P. (2010) · Epidemiology · doi:10.1097/ede.0b013e3181f26e3f · Cited by 168
“11,12,31,32 This literature could be interpreted in 2 ways: (1) some cases of autism spectrum disorders result from adverse conditions caused by altered autoimmune response during the prenatal or early postnatal period, possibly by enhancing susceptibility to other agents, or (2) some familial factors are concurrently…”
BackgroundEvidence supporting an altered immune response in ASD
Mead, J., & Ashwood, P. (2015) · Immunology Letters · doi:10.1016/j.imlet.2014.11.006 · Cited by 165
Self-citationLee, R. W. Y., Corley, M. J., Pang, A., Arakaki, G., Abbott, L., Nishimoto, M., Miyamoto, R., Lee, E., Yamamoto, S., Maunakea, A. K., et al. (2018) · Physiology & Behavior · doi:10.1016/j.physbeh.2018.02.006 · Cited by 165
Tipping the balance of autism risk: potential mechanisms linking pesticides and autism
Shelton, J. F., Hertz-Picciotto, I., & Pessah, I. N. (2012) · Environmental Health Perspectives · doi:10.1289/ehp.1104553 · Cited by 164
“Recent reviews on this topic report altered cytokine profiles, altered cellular immunity, low levels of lymphocytes and T-cell mitogen responses, neuroinflammation, and auto antibodies directed at nuclear proteins (Ashwood et al. 2006; Goines and Van de Water 2010).”
BackgroundWills, S., Cabanlit, M., Bennett, J., Ashwood, P., Amaral, D. G., & Van de Water, J. (2009) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2008.07.007 · Cited by 163
“…natural killer cell lytic activity, abnormal cytokine, and immunoglobulin levels and decreased peripheral lymphocyte numbers, and responsiveness (Ashwood et al., 2006; Croonenberghs et al., 2002; Molloy et al., 2006; Stubbs and Crawford, 1977; Sweeten et al., 2003; Trajkovski et al., 2004;…”
BackgroundSelf-citationUrinary p-cresol is elevated in small children with severe autism spectrum disorder
Altieri, L., Neri, C., Sacco, R., Curatolo, P., Benvenuto, A., Muratori, F., Santocchi, E., Bravaccio, C., Lenti, C., Saccani, M., et al. (2011) · Biomarkers · doi:10.3109/1354750x.2010.548010 · Cited by 161
“Conceivably, an age-dependent maturation of the gut immune system could yield greater control over clostridial overgrowth after 7 years of age, with ASD-specific developmental trajectories stemming from the complex array of immune abnormalities frequently encountered in ASD children (Jyonouchi et al., 2005; Ashwood et…”
BackgroundAhmad, S. F., Zoheir, K. M. A., Ansari, M. A., Nadeem, A., Bakheet, S. A., AL-Ayadhi, L. Y., Alzahrani, M. Z., Al-Shabanah, O. A., Al-Harbi, M. M., & Attia, S. M. (2017) · Molecular Neurobiology · doi:10.1007/s12035-016-9977-0 · Cited by 155
Reduced serum levels of 25-hydroxy and 1,25-dihydroxy vitamin D in egyptian children with autism
Meguid, N. A., Hashish, A. F., Anwar, M., & Sidhom, G. (2010) · The Journal of Alternative and Complementary Medicine · doi:10.1089/acm.2009.0349 · Cited by 154
“These inflammatory mediators show similarity to the immune processes regulated by vitamin D.(38,39) Seizures are common in autism,(40) and activated vitamin D significantly increases the seizure threshold, making the brain tissue less likely to seize.”
Schendel, D. E., DiGuiseppi, C., Croen, L. A., Fallin, M. D., Reed, P. L., Schieve, L. A., Wiggins, L. D., Daniels, J., Grether, J., Levy, S. E., et al. (2012) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-012-1461-8 · Cited by 154
Frye, R. E. (2018) · CNS Drugs · doi:10.1007/s40263-018-0556-y · Cited by 151
“ASD has been associated with prenatal and postnatal infections, familial autoimmunity, and gastrointestinal inflammation, further suggesting a role for the immune system [88].”
BackgroundGut microbiota changes in children with autism spectrum disorder: a systematic review
Ho, L. K. H., Tong, V. J. W., Syn, N., Nagarajan, N., Tham, E. H., Tay, S. K., Shorey, S., Tambyah, P. A., & Law, E. C. N. (2020) · Gut Pathogens · doi:10.1186/s13099-020-0346-1 · Cited by 149
Inoue, R., Sakaue, Y., Sawai, C., Sawai, T., Ozeki, M., Romero-Pérez, G. A., & Tsukahara, T. (2016) · Bioscience, Biotechnology, and Biochemistry · doi:10.1080/09168451.2016.1222267 · Cited by 148
Reconceptualization of translocator protein as a biomarker of neuroinflammation in psychiatry
Notter, T., Coughlin, J. M., Sawa, A., & Meyer, U. (2017) · Molecular Psychiatry · doi:10.1038/mp.2017.232 · Cited by 156
Immune Endophenotypes in Children With Autism Spectrum Disorder
Careaga, M., Rogers, S., Hansen, R. L., Amaral, D. G., Van de Water, J., & Ashwood, P. (2017) · Biological Psychiatry · doi:10.1016/j.biopsych.2015.08.036 · Cited by 143
“Numerous published findings have identified widespread differences in the immune systems of children with ASD, both at the systemic and cellular levels (3).”
BackgroundSelf-citationIn Search of Cellular Immunophenotypes in the Blood of Children with Autism
Ashwood, P., Corbett, B. A., Kantor, A., Schulman, H., Van de Water, J., & Amaral, D. G. (2011) · PLoS ONE · doi:10.1371/journal.pone.0019299 · Cited by 140
“The increased presence of auto-antibodies to brain and CNS proteins is a common finding in autism and may reflect an ongoing inflammatory and or autoimmune process in children with autism that could be initiated by abnormal NK cell activation [6].”
BackgroundSelf-citationAsadabadi, M., Mohammadi, M.-R., Ghanizadeh, A. J., Modabbernia, A., Ashrafi, M., Hassanzadeh, E., Forghani, S., & Akhondzadeh, S. (2012) · Psychopharmacology · doi:10.1007/s00213-012-2796-8 · Cited by 151
“The findings support evidence of pathogenic role of immune system disturbances in these patients (Ashwood et al. 2006, 2011; Careaga et al. 2010).”
Wu, S., Ding, Y., Wu, F., Li, R., Xie, G., Hou, J., & Mao, P. (2015) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2015.05.004 · Cited by 161
Immune-Glutamatergic Dysfunction as a Central Mechanism of the Autism Spectrum Disorders
Blaylock, R., & Strunecka, A. (2009) · Current Medicinal Chemistry · doi:10.2174/092986709787002745 · Cited by 138
“Ashwood with co-workers [81, 82] recently reviewed the immunological abnormalities reported in the ASD, which include abnormal reactivity of lymphocytes, a shift in Th1/Th2 balance, amplified release of TNF- and IL-1ß with mononuclear stimulation, presence of various anti-brain antibodies, and specific antibodies to n…”
BackgroundHaspula, D., & Clark, M. A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21207693 · Cited by 156
“Autism spectrum disorder-mediated immune impairment: Clinical and pre-clinical studies have routinely reported immune dysfunction in autistic individuals [536,537].”
BackgroundAutoantibodies to cerebellum in children with autism associate with behavior
Goines, P., Haapanen, L., Boyce, R., Duncanson, P., Braunschweig, D., Delwiche, L., Hansen, R., Hertz-Picciotto, I., Ashwood, P., & Van de Water, J. (2011) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2010.11.017 · Cited by 134
“, 2005), as well as differences in system-wide humoral and cellular immunity (Ashwood et al., 2006; Pardo et al., 2005).”
BackgroundSelf-citationMankad, D., Dupuis, A., Smile, S., Roberts, W., Brian, J., Lui, T., Genore, L., Zaghloul, D., Iaboni, A., Marcon, P. M. A., et al. (2015) · Molecular Autism · doi:10.1186/s13229-015-0010-7 · Cited by 131
“[16] failed to replicate that finding in 2006, although there was some evidence for such a disturbance in children with a history of regression.”
ResultTwo distinct ontogenies confer heterogeneity to mouse brain microglia
De, S., Van Deren, D., Peden, E., Hockin, M., Boulet, A., Titen, S., & Capecchi, M. R. (2018) · Development · doi:10.1242/dev.152306 · Cited by 130
Inflammation of the Embryonic Choroid Plexus Barrier following Maternal Immune Activation
Cui, J., Shipley, F. B., Shannon, M. L., Alturkistani, O., Dani, N., Webb, M. D., Sugden, A. U., Andermann, M. L., & Lehtinen, M. K. (2020) · Developmental Cell · doi:10.1016/j.devcel.2020.09.020 · Cited by 128
“Immune system disturbances during development increase the susceptibility of offspring to multiple neurodevelopmental disorders (Ashwood et al., 2006; Estes and McAllister, 2016; Knuesel et al., 2014; Patterson, 2011).”
BackgroundMast cell activation and autism
Theoharides, T. C., Angelidou, A., Alysandratos, K.-D., Zhang, B., Asadi, S., Francis, K., Toniato, E., & Kalogeromitros, D. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2010.12.017 · Cited by 125
Gabriele, S., Sacco, R., Cerullo, S., Neri, C., Urbani, A., Tripi, G., Malvy, J., Barthelemy, C., Bonnet-Brihault, F., & Persico, A. M. (2014) · Biomarkers · doi:10.3109/1354750x.2014.936911 · Cited by 125
“Within this framework, the age effect could be due to the maturation of the GI immune system and to its increasing ability to control the overgrowth of cresol-producing bacterial strains (Ashwood et al., 2006; Jyonouchi et al., 2005; Persico & Napolioni, 2012).”
BackgroundAutism and Oxytocin: New Developments in Translational Approaches to Therapeutics
Green, J. J., & Hollander, E. (2010) · Neurotherapeutics · doi:10.1016/j.nurt.2010.05.006 · Cited by 124
Low natural killer cell cytotoxic activity in autism: The role of glutathione, IL-2 and IL-15
Vojdani, A., Mumper, E. A., Granpeesheh, D., Mielke, L., Traver, D., Bock, K., Hirani, K., Neubrander, J. A., Woeller, K. N., O’Hara, N., et al. (2008) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2008.09.005 · Cited by 134
“Immune abnormalities in autism include changes in the numbers and activities ofmacrophages, Tcells, B cells andnatural killer (NK) cell activity (Ashwood et al., 2004; Ashwood et al., 2006; Ashwood and Wakefield, 2006; Stubbs et al.,1977;Warren et al.,1986,1987).”
Role of Microglia in Autism: Recent Advances
Takano, T. (2015) · Developmental Neuroscience · doi:10.1159/000398791 · Cited by 120
A Case Series of a Luteolin Formulation (Neuroprotek®) in Children with Autism Spectrum Disorders
Theoharides, T. C., Asadi, S., & Panagiotidou, S. (2012) · International Journal of Immunopathology and Pharmacology · doi:10.1177/039463201202500201 · Cited by 120
“Brain inflammation in ASD Increasing evidence indicates that there is some immune dysfunction in ASD (15).”
BackgroundImmune dysregulation in autism spectrum disorder
Noriega, D. B., & Savelkoul, H. F. J. (2013) · European Journal of Pediatrics · doi:10.1007/s00431-013-2183-4 · Cited by 139
“From several studies, it is safe to assume that a dysregulation in the immune system is a crucial part in the development of ASD [7].”
BackgroundCattane, N., Richetto, J., & Cattaneo, A. (2020) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2018.07.001 · Cited by 117
Atladóttir, H. Ó., Thorsen, P., Schendel, D. E., Østergaard, L., Lemcke, S., & Parner, E. T. (2010) · Archives of Pediatrics & Adolescent Medicine · doi:10.1001/archpediatrics.2010.9 · Cited by 114
“Findings include decreased response to T-cell mitogens,(2) reduced activity of natural killer cells,(4,5) imbalance in helper T-cell type,(6,7) and altered cytokine levels.(2,7) The following theory of neuroautoimmunity has been proposed: ASDs may be caused by autoimmunity to the brain, possibly triggered by a viral i…”
BackgroundInfluentialGrace, P. M., Rolan, P. E., & Hutchinson, M. R. (2011) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2011.04.003 · Cited by 129
“…with preclinical models of Alzheimer’s disease, Parkinson’s disease, traumatic brain injury, stroke, multiple sclerosis (Amor et al., 2010), autism (Ashwood et al., 2006; Blaylock and Strunecka, 2009), spinal cord injury (Detloff et al., 2008; Ankeny and Popovich, 2009) and schizophrenia…”
BackgroundZerbo, O., Yoshida, C., Grether, J. K., Van de Water, J., Ashwood, P., Delorenze, G. N., Hansen, R. L., Kharrazi, M., & Croen, L. A. (2014) · Journal of Neuroinflammation · doi:10.1186/1742-2094-11-113 · Cited by 115
“Several epidemiological studies have reported immune dysregulation in children with ASD and their mothers, suggesting a role for the immune system in the pathology of the disorder [5-9].”
BackgroundSelf-citationAutism and mitochondrial disease
Haas, R. H. (2010) · Developmental Disabilities Research Reviews · doi:10.1002/ddrr.112 · Cited by 114
The Neurobiology of Lipid Metabolism in Autism Spectrum Disorders
Tamiji, J., & Crawford, D. A. (2010) · Neurosignals · doi:10.1159/000323189 · Cited by 113
“and altered immune responses have been reported in cases of ASD [”
MacFabe, D. F., Rodriguez-, K., Hoffman, J. E., Franklin, A. E., Mohammad-A, Y., Taylor, A. R., Boon, F., Cain, D. P., Kavaliers, M., Possmayer, F., et al. (2008) · American Journal of Biochemistry and Biotechnology · doi:10.3844/ajbbsp.2008.146.166 · Cited by 113
“The similarities in innate neuroinflammatory and oxidative stress changes between the animal model and human ASD cases could represent similar metabolic or immune mediated processes([9]) directly or indirectly associated with PPA.”
BackgroundDietert, R. R., & Dietert, J. M. (2008) · Journal of Toxicology and Environmental Health, Part B · doi:10.1080/10937400802370923 · Cited by 113
“Immune dysfunction was reported as a common occurrence among cases of autism and ASDs (Gupta et al., 1996; Cohly & Panja, 2005; Jyonouchi et al., 2005; Ashwood et al., 2006; Sperner-Unterweger et al., 2006).”
BackgroundInfluentialBent, S., Lawton, B., Warren, T. L., Widjaja, F., Dang, K., Fahey, J. W., Cornblatt, B. S., Kinchen, J. M., Delucchi, K., & Hendren, R. L. (2018) · Molecular Autism · doi:10.1186/s13229-018-0218-4 · Cited by 118
“Prior studies examining physiological abnormalities have examined biomarkers for one particular metabolic pathway (such as cytokines [2], oxidative stress [3], or mitochondrial dysfunction [4]), and a variety of others has been proposed [5].”
BackgroundJyonouchi, H., Geng, L., Cushing-Ruby, A., & Quraishi, H. (2008) · Journal of Neuroinflammation · doi:10.1186/1742-2094-5-52 · Cited by 111
“Moreover, reported results are conflicting; some studies indicate type 1 T-helper (Th1)skewed responses while other studies indicate Th2skewed responses [13-16].”
ResultDo aluminum vaccine adjuvants contribute to the rising prevalence of autism?
Tomljenovic, L., & Shaw, C. A. (2011) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2011.08.008 · Cited by 129
Siniscalco, D., Sapone, A., Giordano, C., Cirillo, A., de Magistris, L., Rossi, F., Fasano, A., Bradstreet, J. J., Maione, S., & Antonucci, N. (2013) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-013-1824-9 · Cited by 121
“Numerous biochemical and cellular events are associated with ADs (i.e. oxidative stress, mitochondrial dysfunction, intestinal dysbiosis and immune dysregulation) (Ashwood et al. 2006; de Magistris et al. 2010).”
BackgroundEnstrom, A. M., de Water, J. V., & Ashwood, P. (2009) · PubMed · Cited by 124
Self-citationSamsam, M. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i29.9942 · Cited by 106
Ivanovska, M., Abdi, Z., Murdjeva, M., Macedo, D., Maes, A., & Maes, M. (2020) · Pharmaceuticals · doi:10.3390/ph13090230 · Cited by 83
Lerer, E., Levi, S., Israel, S., Yaari, M., Nemanov, L., Mankuta, D., Nurit, Y., & Ebstein, R. P. (2010) · Autism Research · doi:10.1002/aur.156 · Cited by 104
“We suggest that the role of CD38 in lymphocyte activation, together with the considerable evidence for an immune system involvement in autism [Ashwood et al., 2006; Atladottir et al., 2009; Dantzer & Kelley, 2008] and the involvement of CD38 in regulation of OT secretion and sociality, points to…”
BackgroundInfluentialIncreased IgG4 levels in children with autism disorder
Enstrom, A., Krakowiak, P., Onore, C., Pessah, I. N., Hertz-Picciotto, I., Hansen, R. L., Van de Water, J. A., & Ashwood, P. (2009) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2008.12.005 · Cited by 101
“Environmental triggers, such as thalidomide, valproic acid, and prenatal and early postnatal infections have also been associated with autism (Ashwood et al., 2006; Fortier et al., 2007; Meyer et al., 2006; Miyazaki et al., 2005; Narita et al., 2002; Niehus and Lord, 2006; Rodier et al., 1997; Rosen et al., 2007; Shi…”
Self-citationCataldo, I., Azhari, A., & Esposito, G. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00027 · Cited by 100
“Maternal infection is hypothesized to trigger a dysregulation in cytokine levels, which disrupts typical neurodevelopment and contributes to ASD (Ashwood et al., 2006, 2011).”
BackgroundScreening for autism in extremely preterm infants: problems in interpretation
Moore, T., Johnson, S. J., Hennessy, E. M., & Marlow, N. (2012) · Developmental Medicine & Child Neurology · doi:10.1111/j.1469-8749.2012.04265.x · Cited by 108
“ations and autism have been reported.(19,20) Reduced natural killer activity, depressed T-cell responses, and low levels of interleukins and immunoglobulins have all been linked, and it has been hypothesized that aberrations in the immune system contribute to neurological dysfunction.”
BackgroundMcGuinn, L. A., Windham, G. C., Kalkbrenner, A. E., Bradley, C., Di, Q., Croen, L. A., Fallin, M. D., Hoffman, K., Ladd-Acosta, C., Schwartz, J., et al. (2020) · Epidemiology · doi:10.1097/ede.0000000000001109 · Cited by 97
Morgan, J. T., Barger, N., Amaral, D. G., & Schumann, C. M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0110356 · Cited by 99
Metadata
- Authors
- Ashwood, P., Wills, S., & Van de Water, J.
- Affiliations
- University of California, Davis (US)
- University of California Davis Medical Center (US)
- Division of Rheumatology, Allergy and Clinical Immunology, University of California Davis , Sacramento
- Corresponding author
- Ashwood, Paul
- ORCID
- Ashwood, Paul
- Venue
- Journal of Leukocyte Biology
- Publisher
- Oxford University Press (OUP)
- Published
- 2006-05-12
- Volume
- 80
- Issue
- 1
- Pages
- 1-15
- ISSN
- 0741-5400 (ISSN-L)
- 1938-3673
- OpenAlex
- W2167538265
- Cited by
- 528
- References
- 202
- Citations by year
- 2026: 6 · 2025: 10 · 2024: 20 · 2023: 8 · 2022: 23 · 2021: 16 · 2020: 25 · 2019: 24 · 2018: 27 · 2017: 30 · 2016: 21 · 2015: 41 · 2014: 26 · 2013: 41 · 2012: 43
- FWCI
- 2.45
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Leukocyte Biology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cognitive Neuroscience › Autism Spectrum Disorder Research
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
- Keywords
- autism spectrum disorder, neuroimmune interactions, immune dysregulation, T-cell mitogen response, immunoglobulin levels, autoimmunity, HLA-DRB1, complement C4, brain development, autism etiology
- MeSH terms
- Animals, Autistic Disorder, Complement C4, T-Lymphocytes, Helper-Inducer, HLA-DR Antigens, Humans, Autoimmunity, HLA-DRB1 Chains
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.